Kovitz Investment Group Partners’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$40.6M	Sell	90,885 -7,490	-8%	-$3.49M	0.94%	19
2025 Q4	$44.6M	Buy	98,375 +17,788	+22%	+$7.67M	0.99%	17
2025 Q3	$31.6M	Buy	80,587 +48,544	+151%	+$20.3M	0.12%	156
2025 Q2	$14.3M	Buy	32,043 +23,574	+278%	+$10.9M	0.06%	245
2025 Q1	$4.11M	Sell	8,469 -8,712	-51%	-$4.06M	0.02%	438
2024 Q4	$6.92M	Sell	17,181 -18,902	-52%	-$8.76M	0.03%	335
2024 Q3	$15.4M	Buy	36,083 +4,638	+15%	+$2.23M	0.11%	167
2024 Q2	$14.7M	Buy	31,445 +29,843	+1,863%	+$13M	0.13%	123
2024 Q1	$670K	Buy	+1,602	New	+$677K	0.01%	463
2022 Q1	–	Sell	-3,128	Closed	-$739K	–	465
2021 Q4	$739K	Sell	3,128 -6,110	-66%	-$1.19M	0.02%	314
2021 Q3	$1.68M	Sell	9,238 -2,420	-21%	-$472K	0.03%	246
2021 Q2	$2.35M	Buy	11,658 +6,040	+108%	+$1.26M	0.05%	225
2021 Q1	$1.21M	Buy	5,618 +2,490	+80%	+$547K	0.03%	265
2020 Q4	$739K	Sell	3,128 -1,610	-34%	-$369K	0.02%	307
2020 Q3	$1.29M	Buy	+4,738	New	+$1.31M	0.04%	237